2025-04-04 19:35:42
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Astec LifeSciences Ltd posts Rs. 9.07 crore consolidated PAT in Q2FY22
Posted On : 2021-10-27 18:54:42( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 103.4737 crores during the period ended September 30, 2021 as compared to Rs. 129.4604 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 9.0724 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 12.9848 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 4.63 for the period ended September 30, 2021 as compared to Rs. 6.62 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 103.4737 crs | ₹129.4604 crs |  -20.07% |
| Net Profit | ₹9.0724 crs | ₹12.9848 crs | -30.13% |
| EPS | ₹4.63 | ₹6.62 | -30.06% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 103.4737 crores during the period ended September 30, 2021 as compared to Rs.156.8469 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.9.0724 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.17.8498 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.4.63 for the period ended September 30, 2021 as compared to Rs.9.11 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 103.4737 crs | ₹156.8469 crs | -34.03% |
| Net Profit | ₹9.0724 crs | ₹17.8498 crs | -49.17% |
| EPS | ₹4.63 | ₹9.11 | -49.18% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.232.9341 crores during the 6 Months period ended September 30, 2021 as compared to Rs.270.0433 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.22.0572 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.34.0314 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.11.25 for the 6 Months period ended September 30, 2021 as compared to Rs.17.37 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹232.9341 crs | ₹270.0433 crs | -13.74% |
| Net Profit | ₹22.0572 crs | ₹34.0314 crs | -35.19% |
| EPS | ₹11.25 | ₹17.37 | -35.23% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1232.40 as compared to the previous close of Rs. 1222.95. The total number of shares traded during the day was 1051 in over 351 trades.
The stock hit an intraday high of Rs. 1242.50 and intraday low of 1210.00. The net turnover during the day was Rs. 1292245.00.
